Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL26085408 | 0.82 | NPSR1 (0.30) | NPSR1 | |
| SCHEMBL18924238 | 0.81 | ALDH1A1 (0.41) | EPHX2NPSR1 | |
| SCHEMBL18924278 | 0.81 | ALDH1A1 (0.41) | EPHX2NPSR1 | |
| SCHEMBL19719269 | 0.79 | — | — | |
| SCHEMBL15243229 | 0.78 | EPHX2 (0.38) | EPHX2NPSR1 | |
| SCHEMBL19961030 | 0.77 | ALDH1A1 (0.43) | EPHX2NPSR1 | |
| SCHEMBL18156659 | 0.76 | NPSR1 (0.34) | NPSR1 | |
| SCHEMBL23425540 | 0.76 | NPSR1 (0.33) | NPSR1 | |
| SCHEMBL26085386 | 0.74 | PRKCA (0.39) | — | |
| SCHEMBL18924276 | 0.74 | PRKCA (0.39) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11036132-B2 | Resist composition, method of forming resist pattern, compound, and acid diffusion control agent | TOKYO OHKA KOGYO CO., LTD. (JP) | 2021-06-15 | — | — | US | disclosed |
| US-20190204735-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, COMPOUND, AND ACID DIFFUSION CONTROL AGENT | TOKYO OHKA KOGYO CO., LTD. (JP) | 2019-07-04 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11036132-B2 | Resist composition, method of forming resist pattern, compound, and acid diffusion control agent | RB1, RBBP5, RBBP4 | EPHX2 2714/4885NPSR1 3438/4885 |
| US-20190204735-A1 | RESIST COMPOSITION, METHOD OF FORMING RESIST PATTERN, COMPOUND, AND ACID DIFFUSION CONTROL AGENT | RB1, RBBP5, RBBP4 | EPHX2 2714/4885NPSR1 3438/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.